MENU
+Compare
INDP
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$11.64
Change
+$1.34 (+13.01%)
Capitalization
6.61M

INDP Indaptus Therapeutics Inc Forecast, Technical & Fundamental Analysis

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INDP with price predictions
Jun 27, 2025

INDP's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for INDP moved out of overbought territory on June 24, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 instances where the indicator moved out of the overbought zone. In of the 19 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INDP broke above its upper Bollinger Band on June 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for INDP entered a downward trend on June 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 72 cases where INDP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 23, 2025. You may want to consider a long position or call options on INDP as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INDP just turned positive on June 03, 2025. Looking at past instances where INDP's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

INDP moved above its 50-day moving average on June 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INDP advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.381) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). INDP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. INDP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INDP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INDP is expected to report earnings to fall 40.62% to -18 cents per share on August 18

Indaptus Therapeutics Inc INDP Stock Earnings Reports
Q2'25
Est.
$-0.19
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.11
The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -18 cents. With 41.48K shares outstanding, the current market capitalization sits at 6.61M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QUIK6.320.35
+5.86%
QuickLogic Corp
MIRM51.090.53
+1.05%
Mirum Pharmaceuticals
BURL230.631.54
+0.67%
Burlington Stores
RBBN3.95-0.08
-1.99%
Ribbon Communications
CHSN0.14-0.01
-3.72%
Chanson International Holding

INDP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-9.45%
UNCY - INDP
52%
Loosely correlated
+14.48%
CDTX - INDP
40%
Loosely correlated
+0.24%
COYA - INDP
25%
Poorly correlated
-0.85%
ISCO - INDP
25%
Poorly correlated
N/A
NUVB - INDP
25%
Poorly correlated
-2.54%
More